Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.


Sci. STKE, 30 March 2004
Vol. 2004, Issue 226, p. tw114
[DOI: 10.1126/stke.2262004TW114]

EDITORS' CHOICE

ENDOCRINOLOGY A New Cardiac Regulator?

Phosphatidylethanolamine-binding protein (PEBP, also called Raf-1 kinase inhibitor protein), which is a precursor to hippocampal cholinergic neurostimulating peptide (HCNP), is found in various tissues, including brain, adrenals, and platelets. Noting that PEBP and HCNP have been found in synaptic vesicles and that HCNP is secreted by hippocampal neurons, Goumon et al. investigated the possible localization of these peptides in adrenal chromaffin cells (which are related developmentally and functionally to sympathetic neurons and, when stimulated, release catecholamines into the blood). The authors used a combination of techniques to show that PEBP could be found in the cytoplasm and the secretory granules of cultured bovine adrenal chromaffin cells. Stimulation of the cells with increased extracellular concentrations of K+ or with nicotine led to PEBP release into the extracellular solution with a similar time course and nicotine concentration dependence as for release of chromagranin A (a known constituent of chromaffin granules). PEBP was also secreted by platelets treated with thrombin receptor-activating peptide and could be detected in bovine serum. The authors used two-dimensional liquid chromatography-tandem mass spectrometry to show that HCNP was also present in chromaffin granules. Suspecting a possible endocrine role--and based on the known effects of catecholamines and the chromagranin A-derivative vasostatin I--the authors examined the effects of HCNP on isolated frog heart and discovered that it decreased stroke volume and stroke work and counteracted the positive inotropic effects of the β-adrenergic agonist isoproterenol. Thus, HCNP may represent a new endocrine modulator of cardiac physiology.

V. Goumon, T. Angelone, F. Schoentgen, S. Chasserot-Golaz, B. Almas, M. M. Fukami, K. Langley, I. D. Welters, B. Tota, D. Aunis, M.-H. Metz-Boutigue, The hippocampal cholinergic neurostimulating peptide, the N-terminal fragment of the secreted phosphatidylethanolamine-binding protein, possesses a new biological activity on cardiac physiology. J. Biol. Chem. 279, 13054-13064 (2004). [Abstract] [Full Text]

Citation: A New Cardiac Regulator? Sci. STKE 2004, tw114 (2004).


To Advertise     Find Products


Science Signaling. ISSN 1937-9145 (online), 1945-0877 (print). Pre-2008: Science's STKE. ISSN 1525-8882